![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
EARLY TREATMENT OF HEPATITIS C VIRUS IMPROVES HEALTH OUTCOMES AND YIELDS COST-SAVINGS: A MODELING STUDY IN ARGENTINA
|
|
|
EASL European Association for the Study of the Liver's 55th Annual International Liver Congress, London, United Kingdom
Reported by Jules Levin
Jorge Federico Elgart1; Mariana Glancszpigel2; Natalia Albaytero2; Diego Kanevsky3; Maria Florencia Rodriguez3; Manuel Mendizabal4; Yuri Sanchez Gonzalez5
1CENEXA (Center of Experimental and Applied Endocrinology), Universidad Nacional de La Plata-CONICET, La Plata, Argentina); 2Eff, Buenos Aires, Argentina; 3AbbVie Argentina; 4Hepatology and Liver Transplant Unit, Hospital Universitario Austral, Pilar, Buenos Aires, Argentina; 5AbbVie Inc., North Chicago, United States
![0827201](../images/082620/082620-5/0827201.gif)
![0827202](../images/082620/082620-5/0827202.gif)
![0827203](../images/082620/082620-5/0827203.gif)
![0827204](../images/082620/082620-5/0827204.gif)
![0827205](../images/082620/082620-5/0827205.gif)
![0827206](../images/082620/082620-5/0827206.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|